These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7489757)

  • 1. Allo-skin graft rejection, tumor rejection and natural killer activity in mice lacking p56lck.
    Wen T; Zhang L; Kung SK; Molina TJ; Miller RG; Mak TW
    Eur J Immunol; 1995 Nov; 25(11):3155-9. PubMed ID: 7489757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of natural killer and killer cells in concordant xenograft rejection.
    Patselas T; Thomas F; Araneda D; Marchman W
    Transplant Proc; 1995 Feb; 27(1):262-3. PubMed ID: 7878995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p56lck is not essential for the T-cell response to allo-MHC antigens.
    Yamada H; Kong YY; Kishihara K; Mak TW; Nomoto K
    Immunology; 1997 Sep; 92(1):33-8. PubMed ID: 9370921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of src family lck tyrosine kinase following interleukin-12 activation of human natural killer cells.
    Pignata C; Prasad KV; Hallek M; Druker B; Rudd CE; Robertson MJ; Ritz J
    Cell Immunol; 1995 Oct; 165(2):211-6. PubMed ID: 7553885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the p56lck protein tyrosine kinase with the Fc gamma RIIIA/CD16 complex in human natural killer cells.
    Cone JC; Lu Y; Trevillyan JM; Bjorndahl JM; Phillips CA
    Eur J Immunol; 1993 Oct; 23(10):2488-97. PubMed ID: 8405050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G; Anderson CG; Warner J
    J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance.
    Dennert G; Anderson CG; Warner J
    J Immunol; 1985 Dec; 135(6):3729-34. PubMed ID: 3905963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein tyrosine phosphorylation and p56lck modification in IL-2 or phorbol ester-activated human natural killer cells.
    Einspahr KJ; Abraham RT; Dick CJ; Leibson PJ
    J Immunol; 1990 Sep; 145(5):1490-7. PubMed ID: 1696599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-linking of CD45 on NK cells stimulates p56lck-mediated tyrosine phosphorylation and IFN-gamma production.
    Xu X; Chong AS
    J Immunol; 1995 Dec; 155(11):5241-8. PubMed ID: 7594536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profound block in thymocyte development in mice lacking p56lck.
    Molina TJ; Kishihara K; Siderovski DP; van Ewijk W; Narendran A; Timms E; Wakeham A; Paige CJ; Hartmann KU; Veillette A
    Nature; 1992 May; 357(6374):161-4. PubMed ID: 1579166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc gamma RIIIA-mediated signaling involves src-family lck in human natural killer cells.
    Pignata C; Prasad KV; Robertson MJ; Levine H; Rudd CE; Ritz J
    J Immunol; 1993 Dec; 151(12):6794-800. PubMed ID: 8258691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
    Hinuma S; Naruo K; Shiho O; Tsukamoto K
    Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
    Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
    Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 does not overcome suppression of graft rejection by cyclosporin A: effect of cyclosporin A on T cell properties in vivo.
    Magae J; Matsubara H; Aotsuka N; Kurasawa K; Shearer GM
    Cell Immunol; 1996 Nov; 173(2):276-81. PubMed ID: 8912887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
    Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
    J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.